Lumito want to streamline tissue diagnostics by offering instrument and reagents for diagnostic support to an international market. This is done by creating the opportunity for multiplexing and quantification. A more efficient tissue diagnosis means safer, and the possibility of automated, diagnoses. The Company plan to reach the market during 2020 via validation of the instruments at reference clinics.
The Company plan to reach the market by first establish partnerships with reference customers and then build a network of distribution channels. The European market is first priority.